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ABSTRACT 
Antimicrobial resistance is a public health concern for both human and veterinary medicine. In 
food animal production systems, medically important antimicrobials are used for both 
prophylactic and therapeutic purposes; therefore, food animals have the potential to serve as a 
reservoir for antimicrobial resistant bacteria. Previous research has shown an uneven distribution 
of resistance with a higher prevalence within young animals; however, limited research has 
addressed antimicrobial resistance within veal production systems. Vertically integrated veal 
production systems provide a unique opportunity to study the transmission of resistance through 
the food supply. The study’s objective was to estimate the prevalence of antimicrobial resistant 
Escherichia coli within different stages of a vertically integrated veal production system. A total 
of 377 fecal samples were collected from nine different calf cohorts on six farms, where the 
average age was 69 days (range: 8-115). Four of these cohorts were followed to harvest for 
additional sample collection. At harvest, a total of 159 fecal samples, 161 pre-evisceration and 
150 post-evisceration carcass swabs were collected. A single E. coli isolate from the samples was 
subjected to twelve antimicrobials using Kirby-Bauer disk diffusion assays. Zones of growth 
inhibition were measured for each antimicrobial and classified as resistant or susceptible based 
on CLSI interpretive criteria. E. coli Isolates were obtained from 100% of fecal samples, 52% 
(84/161) of pre-evisceration swabs and 16% (24/150) of post-evisceration swabs. Greater than 
98% (372/377) of isolates obtained from farm fecal samples were resistant to two or more 
classes of antimicrobials. A decrease in resistance was seen at harvest where only 46.9% 
(73/159), 69.0% (58/84), and 29.2% (7/24) of isolates from fecal samples, pre-evisceration and 
post-evisceration carcass swabs, were resistant to two or more antimicrobials. These results 
provide insight to the current prevalence of resistance among the production system and the 
opportunity for further research to determine factors affecting the prevalence of resistance. 
INTRODUCTION 
For more than 50 years, antimicrobial drugs have been used for health benefits in both 
human and veterinary medicine; however, development of bacterial resistance to antimicrobials 
is an increasing public health concern (1). According to the Centers for Disease Control and 
Prevention, over 2 million people in the United Stated become infected with bacteria that are 
resistant to antimicrobials, leading to over 23,000 deaths per year (2). Although the percentage of 
these resistant infections attributable to antimicrobial use in livestock production is unknown, it 
is estimated that 80% of antibiotics sold in the United States are used in animal production 
systems (7). These antibiotics are used for disease prevention and treatment as well as growth 
promotion. In addition to treating sick or injured animals, antimicrobials are often given at low 
levels as a preventative measure to minimize the spread of disease during vulnerable times in the 
production process. Furthermore, to increase feed efficiency, enhance growth rates and maximize 
production potential, antibiotics are often given at low doses to select for beneficial 
microorganisms within the gut.    
Food producing animals are colonized with bacteria that are commensals or opportunistic 
pathogens. Antimicrobials exert a selective pressure for bacteria capable of withstanding their 
effects, and may inadvertently create a reservoir of resistant bacteria (6). As the prevalence of 
antimicrobial resistance increases in food animals, the concern of transmission to humans and the 
food supply increases. Transmission may occur through direct contact with animals or 
contamination of animal food products. Animal products can be contaminated on farm or during 
the harvest process through contact with intestinal contents, the animal hide or the environment. 
Although transmission is often associated with known pathogenic bacteria, such as Salmonella, it 
may also occur through commensal organisms, such as Escherichia coli. Commensal organisms 
are more prevalent than pathogens, and often contain mobile resistance elements which can be 
transmitted to other bacteria and pathogens through horizontal gene transfer (5). 
Since E. coli is a known commensal organism with the ability to harbor and transfer 
resistance genes, it is often used as an indicator organism to estimate the prevalence of 
antimicrobial resistance (AMR). Previous research had demonstrated that the prevalence of 
AMR bacteria is not equally distributed across all age groups in cattle (5). It is know that 
younger animals usually have higher levels of resistant bacteria, independent of exposure to 
antimicrobial drugs (5). Since veal calves enter the food system at a young age, vertically 
integrated veal production systems provide a unique opportunity to study the transmission of 
resistance through the food supply.  
The objective of this study was to estimate the prevalence of antimicrobial resistant E. 
coli at different time points in a vertically integrated veal calf production system. In addition, the 
study aimed to provide preliminary data for future studies investigating factors that may 
influence resistance in the veal calf production system. The hypothesis for the study was that the 
prevalence of antimicrobial resistance E. coli would decrease as calves move through the 
production system.  
MATERIALS AND METHODS 
For this study, a longitudinal observational design was utilized. Nine calf cohorts from 
five different farms were sampled on farm, and four of the calf cohorts were followed to harvest 
where additional samples were obtained. On farm, fecal samples were collected from 
approximately 42 calves per farm using rectal palpation techniques. Where necessary, sampled 
calves were given ear tags so they could later be identified at harvest. From the four cohorts 
followed to harvest, sterile cotton swabs were used to collect additional fecal samples from the 
rectum of the gastrointestinal tract following evisceration. In addition, 10 inch by 10 inch pre-
evisceration and post-evisceration carcass swabs were collected from behind the shoulder using 
sterile sponges following USDA protocol (3). The sterile sponges were saturated with 25 mL of 
tryptic soy broth on-site prior to swabbing the carcass. The pre-evisceration carcass swab was 
obtained from the left side of the carcass immediately following the dehiding of the carcass. The 
post-evisceration carcass swabs were collected in the cold room from the right side of the carcass 
following the lactic acid wash. 
Collected samples were brought to the Department of Veterinary Preventative Medicine, 
The Ohio State University for processing. A cotton swab from each fecal sample was plated onto 
MacConkey agar for isolation of gram-negative bacteria. In the lab, an additional 80 mL of 
tryptic soy broth was added to each Whirl-Pak containing a sponge used for the carcass swab. 
These sponges were then incubated at 25 °C for 2 hours followed by 42 °C for 6 hours. The 
sponges were then kept at 4 °C until the following day when they were plated onto MacConkey 
agar (3).   If the samples plated on MacConkey agar grew colonies phenotypically consistent 
with Escherichia coli, one of the colonies was randomly selected and isolated for further testing. 
After isolation, the isolates were subjected to indole testing for confirmation of E. coli. Indole 
positive colonies were presumed to be E. coli.  
The Kirby-Bauer disk diffusion assay was used to test for resistance to twelve different 
antimicrobials: ampicillin (10µg), tetracycline (30µg), neomycin (30µg), gentamicin (10µg), 
chloramphenicol (30µg), ceftiofur (30µg), nalidixic acid (30µg), sulfamethoxazole trimethoprim 
(23.75; 1.25 µg), cefoxitin (30µg), ciprofloxacin (5µg), ceftriaxone (30µg), and streptomycin 
(10µg). To perform the assay, a colony from each isolate was used to inoculate a test tube of 
phosphate buffered saline to match the turbidity of a 0.5 McFarland standard. Turbidity was 
subjectively confirmed using a purchased standard and a Wickerham card. After subjective 
confirmation, the absorbance of the inoculations were read at 625 nm using a Thermo-Scientific 
SPECTRONIC 200 Visible Spectrophotometer to ensure consistency among tested samples; 
excepted absorbance readings were between 0.08-0.13. After obtaining the proper dilution, a 
sterile cotton swab was saturated with the inoculation and used to streak a lawn on a 150 mm 
plate of Mueller-Hinton agar. Following the inoculation of the media, the twelve antimicrobials 
were placed on agar using a dispenser. After incubating for 18-24 hours, each antimicrobials 
zone of inhibition was measured in millimeters for each sample. Samples were determined to be 
susceptible, intermediate, or resistant to each antimicrobial using breakpoints determined by the 
Clinical Laboratories Standard Institute (CLSI). Currently there are no CLSI breakpoints to 
analyze ceftiofur resistance in E. coli of bovine origin; therefore, the resistance breakpoints for 
bovine respiratory disease were used following the study conducted by Donaldson et al (4).  
ATCC control strains E. coli 29522, Staphylococcus aureus 25923, and Pseudomonas 
aeruginosa 27853 were used as controls. 
To test the hypothesis that the prevalence of resistance in E. coli isolates changed through 
production stages, isolates recovered from farm fecal samples, harvest fecal samples, pre-
evisceration swabs, and post-evisceration swabs were categorized as having reduced 
susceptibility or no reduced susceptibility. The isolate categorization for each antimicrobial was 
included as the response variable separate generalized linear mixed models. Farm and Time 
(production stage) were included as a fixed effects, and a random intercept was included for the 
calf. P-values less than 0.05 were considered statistically significant.  
RESULTS 
E. coli was recovered from all of the fecal samples collected on farm and fecal samples 
collected from viscera at harvest. When analyzing resistance among farm fecal samples, more 
than 98% (372/377) were resistant to two or more antimicrobials tested while only 0.5% (2/377) 
were pansusceptible to the antimicrobials tested.  Resistance among the farm fecal isolates was 
greater than 50% for the following five antimicrobials: ampicillin, chloramphenicol, neomycin, 
streptomycin, sulfamethoxazole trimethoprim, and tetracycline (Figure 1).  
Figure 1: Proportion of E. coli isolates collected on farms resistant to twelve antimicrobials  
 
The Kirby-Bauer assay allowed for common resistance phenotypes to be determined 
(Table 1). These resistance phenotypes may indicate resistance genes carried by each isolate. In 
addition, resistance phenotypes may be compared with antimicrobial treatment records to 
identify associations with antimicrobial use. To determine if the farm isolates carry resistance 
genes with the potential to undergo horizontal gene transfer, additional genotypic work would be 
required. 
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Table 1: Resistance Phenotypes among Farm Fecal Samples
 
1 2 3a 3b 4 5 6 7 8
Collective 
(% )
Total
AMP-CHL-NEO-STR-SXT-TET 28.6 16.7 31.7 33.3 43.9 16.7 - 7.0 23.8 22.28% 84
AMP-NEO-STR-SXT-TET 21.4 2.4 2.4 38.1 17.1 9.5 9.5 18.6 11.9 14.59% 55
AMP-CHL-GEN-NEO-STR-SXT-TET 4.8 - 56.1 14.3 4.9 14.3 16.7 4.7 2.4 13.00% 49
AMP-CHL-FOX-GEN-NEO-STR-SXT-TET - 11.9 - 2.4 2.4 11.9 14.3 11.6 7.1 6.90% 26
AMP-CHL-FOX-NEO-STR-SXT-TET 2.4 28.6 - - - 4.8 4.8 2.3 2.4 5.04% 19
AMP-GEN-NEO-STR-SXT-TET 4.8 2.4 2.4 4.8 2.4 - 7.1 14.0 - 4.24% 16
AMP-CHL-FOX-GEN-NEO-STR-SXT-TET-XNL - 11.9 - - - 9.5 2.4 4.7 2.4 3.45% 13
AMP-CHL-NEO-SXT-TET 4.8 - - - 9.8 4.8 - 2.3 - 2.39% 9
AMP-CIP-CHL-GEN-NEO-NAL-STR-SXT-TET - - - 4.8 - 4.8 - - 11.9 2.39% 9
AMP-CHL-FOX-NEO-STR-SXT-TET-XNL - 7.1 2.4 - - 2.4 - - 2.4 1.59% 6
AMP-NEO-STR-TET 11.9 - - - - - - - - 1.33% 5
AMP-CHL-GEN-NEO-NAL-STR-SXT-TET 2.4 2.4 - - - 2.4 - - 4.8 1.33% 5
NEO--STR-SXT-TET - - - - 4.9 2.4 - - 2.4 1.06% 4
AMP-CHL-NEO-STR-TET - - - - - - - 9.3 - 1.06% 4
AMP-FOX-GEN-NEO-STR-SXT-TET - - - - - - 7.1 - - 0.80% 3
AMP-FOX-GEN-NEO-STR-SXT-TET-XNL - 4.8 - - - - - 2.3 - 0.80% 3
AMP-CHL-GEN-STR-SXT-TET 2.4 - - - - - 4.8 - - 0.80% 3
AMP-CHL-FOX-GEN-NEO-STR-TET - - - - - - - 7.0 - 0.80% 3
AMP-AXO-CHL-FOX-NEO-STR-SXT-TET-XNL - 2.4 2.4 - - - 2.4 - - 0.80% 3
AMP-CIP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - 4.8 2.4 - - 0.80% 3
PANSUSCEPTIBLE - 2.4 - - 2.4 - - - - 0.53% 2
AMP-STR-SXT-TET 2.4 - - - - - 2.4 - - 0.53% 2
AMP-NEO-SXT-TET 2.4 - - - 2.4 - - - - 0.53% 2
AMP-NEO-NAL-STR-SXT-TET 2.4 - - - 2.4 - - - - 0.53% 2
AMP-FOX-NEO-STR-SXT-TET - - - - 2.4 - - 2.3 - 0.53% 2
AMP-CHL-GEN-NEO-STR-TET - - - - - - 2.4 2.3 - 0.53% 2
AMP-CHL-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - - - - 4.8 0.53% 2
AMP-CHL-FOX-NEO-SXT-TET 4.8 - - - - - - - - 0.53% 2
AMP-CHL-FOX-NEO-NAL-STR-SXT-TET - - - - - - - - 4.8 0.53% 2
AMP-CHL-FOX-GEN-STR-SXT-TET - - - - - - 4.8 - - 0.53% 2
AMP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET - - - - - - - 2.3 2.4 0.53% 2
AMP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - 2.4 - - 2.4 0.53% 2
AMP-AXO-FOX-NEO-STR-SXT-TET-XNL 2.4 - - - - - 2.4 - - 0.53% 2
AMP-AXO-CHL-FOX-GEN-NEO-STR-SXT-TET-XNL - - - - - 2.4 2.4 - - 0.53% 2
AMP-CIP-CHL-NEO-NAL-STR-SXT-TET - - 2.4 - - - - 2.3 - 0.53% 2
AMP-CIP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET - - - - - - 2.4 2.3 - 0.53% 2
AMP-CIP-AXO-CHL-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - - - 2.3 2.4 0.53% 2
AMP-CIP-AXO-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - - 4.8 - - 0.53% 2
TET 2.4 - - - - - - - - 0.27% 1
STR - 2.4 - - - - - - - 0.27% 1
GEN-STR-SXT-TET - - - - - - 2.4 - - 0.27% 1
CHL-GEN-NEO-STR-SXT-TET - - - - - 2.4 - - - 0.27% 1
CIP - - - - 2.4 - - - - 0.27% 1
CIP-CHL-GEN-NEO-NAL-STR-SXT-TET - - - - - - - - 2.4 0.27% 1
AMP-SXT-TET - - - - 2.4 - - - - 0.27% 1
AMP-NEO-STR - - - - - - - 2.3 - 0.27% 1
AMP-CHL-NEO-STR-SXT-TET-XNL - 2.4 - - - - - - - 0.27% 1
AMP-CHL-NEO-NAL-STR-SXT-TET - - - - - - - - 2.4 0.27% 1
AMP-CHL-FOX-STR-TET - 2.4 - - - - - - - 0.27% 1
AMP-AXO-CHL-GEN-NEO-NAL-STR-SXT-TET-XNL - - - - - - - - 2.4 0.27% 1
AMP-AXO-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL - - - 2.4 - - - - - 0.27% 1
AMP-CIP-CHL-NEO-STR-SXT-TET - - - - - - - - 2.4 0.27% 1
AMP-CIP-CHL-FOX-NEO-NAL-STR-SXT-TET - - - - - - - - 2.4 0.27% 1
AMP-CIP-CHL-FOX-GEN-NEO-STR-SXT-TET-XNL - - - - - 2.4 - - - 0.27% 1
CHL-GEN-NEO-STR-TET - - - - - - 2.4 - - 0.27% 1
Total Number of Isolates 42 42 41 42 41 42 42 43 42 377
Resistance Phenotypes of Farm Fecal Samples
Phenotype
Farm (Percentage of Isolates)
  For the longitudinal portion of the study, the calves sampled on farms 1, 2, 3a, and 4 were 
followed to harvest for additional sample collection. In regards to the fecal samples collected at 
harvest, 52% (73/159) of E. coli isolates were resistant to two or more antimicrobials while the 
remaining 38% were pansusceptible. When evaluating the collected carcass swabs, E. coli was 
isolated from 52% (84/161) and 16% (24/150) of pre-evisceration and post-evisceration swabs 
respectively. Among the pre-evisceration carcass swabs, 36% (56/161) of the samples had an 
isolate that was resistant to at least two of the antimicrobials tested while 17.85% were 
pansusceptible. Of the post-evisceration swabs, fewer isolates were resistant to more than one 
antimicrobial tested, 4.6% (7/150) while 41.67% were pansusceptible to the panel of twelve 
antimicrobials tested.  
There was a general decrease in the prevalence of resistance between the fecal samples 
collected on farm and at harvest. For 9 of the 12 tested antimicrobials, this decrease was 
statistically significant. In contrary to the proposed hypothesis, there was a numerical increase in 
the proportion of isolates resistant between harvest fecal samples and pre-evisceration carcass 
swabs for 7 of the 12 antimicrobials tested, with five having a statistically significant increase. 
When comparing the prevalence of resistance among pre-evisceration swabs to post-evisceration 
swabs, there was a decrease in prevalence in nine of the antimicrobials but only tetracycline had 
a statistically significant decrease (Figure 2). 
Figure 2: Proportion of E. coli Isolates Resistant from the Four Cohorts Sampled at Four Time 
Points and their Statistical Significance for each Antimicrobial 
 
As previously mentioned, the Kirby-Bauer disk diffusion assay can be utilized to 
determine resistance phenotypes. Resistance phenotypes were determined for each isolate 
collected and the percentage of isolates for each phenotype was calculated. Table 2 shows 
common phenotypes found among all of the isolates and their prevalence at each sampling stage. 
Similar phenotypes among isolates collected at various time points may indicate transmission of 
the bacteria but would require genotypic work for confirmation. 
 
 
 
 
 
 
 
 
Table 2: Common Resistance Phenotypes Found Among the Four Time Points Sampled 
 
Phenotype
Farm      
Fecal
Harvest 
Fecal
Pre-
Evisceration
Post-
Evisceration
Collective 
(%)
Total # 
Isolates
AMP-CHL-NEO-STR-SXT-TET 22.3 7.5 21.4 12.5 18.2% 117
Pansusceptible 0.5 39.0 17.9 41.7 13.8% 89
AMP-NEO-STR-SXT-TET 14.6 8.2 4.8 - 11.2% 72
AMP-CHL-GEN-NEO-STR-SXT-TET 13.0 - - - 7.6% 49
TET 0.3 12.6 10.7 20.8 5.4% 35
AMP-CHL-FOX-GEN-NEO-STR-SXT-TET 6.9 - - - 4.0% 26
AMP-CHL-FOX-NEO-STR-SXT-TET 5.0 2.5 1.2 - 3.7% 24
AMP-GEN-NEO-STR-SXT-TET 4.2 3.1 1.2 - 3.4% 22
AMP-CHL-NEO-SXT-TET 2.4 1.9 2.4 - 2.2% 14
AMP-CHL-FOX-GEN-NEO-STR-SXT-TET-XNL 3.4 0.6 - - 2.2% 14
AMP-CIP-CHL-GEN-NEO-NAL-STR-SXT-TET 2.4 - - - 1.4% 9
STR-TET - 3.1 2.4 - 1.1% 7
AMP-TET - 2.5 3.6 - 1.1% 7
AMP-NEO-STR-TET 1.3 0.6 1.2 - 1.1% 7
NEO-STR-TET - 2.5 1.2 4.2 0.9% 6
AMP-CHL-FOX-NEO-STR-SXT-TET-XNL 1.6 - - - 0.9% 6
AMP-CHL-NEO-STR-TET 1.1 - 1.2 - 0.8% 5
AMP-CHL-GEN-NEO-NAL-STR-SXT-TET 1.3 - - - 0.8% 5
STR 0.3 1.3 1.2 - 0.6% 4
NEO-STR-SXT-TET 1.1 - - - 0.6% 4
AMP-STR-TET - 1.3 2.4 - 0.6% 4
AMP-STR-SXT-TET 0.5 - 2.4 - 0.6% 4
AMP-NEO-NAL-STR-SXT-TET 0.5 - 2.4 - 0.6% 4
AMP-FOX-NEO-STR-SXT-TET 0.5 1.3 - - 0.6% 4
AMP-CHL-STR-TET - 0.6 2.4 4.2 0.6% 4
AMP-CIP-CHL-NEO-NAL-STR-SXT-TET 0.5 - 2.4 - 0.6% 4
NEO-TET - 1.9 - - 0.5% 3
NEO-SXT-TET - 1.3 1.2 - 0.5% 3
CHL-STR-TET - 0.6 2.4 - 0.5% 3
AMP-FOX-GEN-NEO-STR-SXT-TET 0.8 - - - 0.5% 3
AMP-FOX-GEN-NEO--STR-SXT-TET-XNL 0.8 - - - 0.5% 3
AMP-CHL-STR-SXT-TET - - 2.4 4.2 0.5% 3
AMP-CHL-GEN-STR-SXT-TET 0.8 - - - 0.5% 3
AMP-CHL-FOX-NEO-SXT-TET 0.5 - 1.2 - 0.5% 3
AMP-CHL-FOX-GEN-NEO-STR-TET 0.8 - - - 0.5% 3
AMP-AXO-CHL-FOX-NEO-STR-SXT-TET-XNL 0.8 - - - 0.5% 3
AMP-CIP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL 0.8 - - - 0.5% 3
NAL - 0.6 - 4.2 0.3% 2
CHL-NEO-SXT-TET - - 2.4 - 0.3% 2
CHL-GEN-STR-SXT-TET 0.5 - - - 0.3% 2
AMP-NEO-SXT-TET 0.5 - - - 0.3% 2
AMP-FOX-STR-SXT-TET - 1.3 - - 0.3% 2
AMP-CHL-GEN-NEO-STR-TET 0.5 - - - 0.3% 2
AMP-CHL-GEN-NEO-NAL-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
AMP-CHL-FOX-NEO-NAL-STR-SXT-TET 0.5 - - - 0.3% 2
AMP-CHL-FOX-GEN-STR-SXT-TET 0.5 - - - 0.3% 2
AMP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET 0.5 - - - 0.3% 2
AMP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
AMP-AXO-FOX-NEO-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
AMP-AXO-CHL-FOX-GEN-NEO-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
AMP-CIP-CHL-FOX-NEO-NAL-STR-SXT-TET 0.3 - 1.2 - 0.3% 2
AMP-CIP-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET 0.5 - - - 0.3% 2
AMP-CIP-AXO-CHL-GEN-NEO-NAL-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
AMP-CIP-AXO-CHL-FOX-GEN-NEO-NAL-STR-SXT-TET-XNL 0.5 - - - 0.3% 2
OTHER 3.7 5.7 7.1 8.3 4.8% 31
 Total Number of Isolates 377 159 84 24 644
Common  Resistance Phenotypes Among Sampling Time Points
Percentage of Isolates
DISCUSSION 
The objective of this study was to estimate the prevalence of antimicrobial resistance at 
various time points within a vertically integrated veal calf production system, and provide 
preliminary data for future research projects to reduce the prevalence of antimicrobial resistance. 
The hypothesis was that the prevalence of antimicrobial resistance would decrease between each 
time point with resistance being highest in fecal samples collected on farm and continuing to 
decrease as the calf moves throughout the production and harvest process. The expected results 
were that resistance would decrease between farm fecal samples, harvest fecal samples, pre-
evisceration carcass swabs, and post-evisceration carcass swabs. Results obtained from the fecal 
samples collected during this study support current literature with prevalence of resistance being 
higher in younger animals and declining as the animal matures. This decrease believed to be 
associated with higher levels of antimicrobial use for preventative measures and growth 
promotion and the maturation of the microflora of the gastrointestinal tract (5). 
 Looking beyond the fecal samples and to the potential transmission of antimicrobial 
resistance into the food supply, carcass contamination is thought to occur from contact with the 
animal hide during the dehiding process. From the pre-evisceration carcass samples collected, E. 
coli was isolated from 52% (73/159) of the swabs supporting this belief. Of the isolates 
recovered, the prevalence of resistance was expected to be similar to or lower than the 
prevalence of the harvest fecal samples because of fecal contamination of the hide. Contrary to 
the proposed hypothesis, a statistically significant increase in the prevalence of resistance was 
seen between harvest fecal samples and pre-evisceration carcass swabs for 7 of the 12 
antimicrobials tested. These results may indicate that the population of bacteria found on the hide 
varies from the bacteria found within the gastrointestinal tract, with the prevalence of resistance 
being higher in the bacteria on the hide than within the gastrointestinal tract.  
At the final sampling point, E. coli was recovered from 16% (24/150) of post-
evisceration swabs with a general decrease in the prevalence of resistance between pre-
evisceration and post-evisceration. Although a reduction in resistance was seen and the general 
trend observed supports the hypothesis, it was only statistically significant for tetracycline. This 
may be due to the lower number of isolates obtained from post-evisceration carcass swabs 
(n=24) compared to the pre-evisceration swabs (n=84) and the ability to deduce statistical 
significance. 
CONCLUSION 
 The purpose of this study was to obtain observational data on the prevalence of 
antimicrobial resistance at various time points in a vertically integrated veal calf production 
system. The data reported is an overview of all of the farms and calf cohorts sampled and 
provides critical data to assess the transmission of antimicrobial resistance into the human food 
supply. Although a general decreasing trend was observed, the results from the post-evisceration 
carcass swabs show that resistant bacteria are making it into the food supply creating a public 
health concern. These bacteria have the potential to transfer resistance genes to pathogenic 
bacteria and create a problem with treating diseases which affect humans.  
With the data collected from this study, future research studies should focus on reducing 
the prevalence of antimicrobial resistance in the veal calf production system. Studies should look 
at factors that influence the prevalence of resistance at the various time points sampled. Not only 
should ways of reducing the prevalence be examined, an emphasis should be placed on reducing 
the transmission into the human food supply.  
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